Product Program year 2025 Source: CMS Open Payments

Visby Medical Respiratory Health Test

Device Respiratory Heath Test

Open in the dashboard

General payments

$92,547

34 payments

Research payments

$4,064,022

173 payments

Through program year 2025, $92,547 in general payments and $4,064,022 in research payments were reported against Visby Medical Respiratory Health Test (Respiratory Heath Test).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $39,636 4
2024 General $73,418 30
2024 Research $1,380,250 80
2023 Research $496,653 14
2022 General $19,129 4
2022 Research $2,147,483 75

Breakdown

Who paid General payments · program years 2022–2024
  1. Visby Medical, Inc. $92,547 34 payments
Top recipients General payments · program year 2024
  1. Angela Caliendo Infectious Disease · Providence, RI $20,000 27% · 4 payments
  2. Richard Whitley Pediatric Infectious Diseases · Birmingham, AL $20,000 27% · 4 payments
  3. Edward Hook Infectious Disease · Birmingham, AL $15,000 20% · 4 payments
  4. David Relman Infectious Disease · Palo Alto, CA $15,000 20% · 4 payments
  5. Jeffrey Klausner Infectious Disease · Los Angeles, CA $3,188 4% · 2 payments

The top 5 of 17 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Infectious Disease Internal Medicine $53,188 72% · 4 practitioners
  2. Pediatric Infectious Diseases Pediatrics $20,000 27% · 1 practitioner
  3. Obstetrics & Gynecology $54 <1% · 4 practitioners
  4. Pediatrics $54 <1% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $39 <1% · 2 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Alabama $35,000 48% · 2 recipients
  2. Rhode Island $20,000 27% · 1 recipient
  3. California $18,188 25% · 2 recipients
  4. Illinois $123 <1% · 5 recipients
  5. Michigan $81 <1% · 6 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

34 general · 173 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record